As per Future Market Insights (FMI) analysis, the global consumption of eubiotics increased by year-on-year (YoY) rate of 6.7% in 2021 to total sales of US$ 2.68 Bn in the year. The overall demand for eubiotics represents 16.4% of the global animal feed market in 2021 and is poised to increase at 7.4% CAGR to reach a value of US$ 5.47 Bn in 2031.
In the evolving landscape of global agriculture, a significant paradigm shift is underway as the world unites against the rise of anti-microbial resistance (AMR). A groundbreaking study reveals that a staggering 70% of antibiotics used worldwide are deemed medically crucial for livestock, presenting a complex challenge that demands strategic intervention on a global scale.
The varied application of antibiotics in farmed animals raises critical concerns, with swine emerging as the highest consumers, closely followed by poultry and ruminants. As the industry transitions away from traditional antibiotic growth promoters (AGPs), sustainable alternatives like eubiotics are gaining prominence, offering a beacon of hope in the fight against AMR.
The European Union (EU) Commission took a pioneering step in 2006 by imposing a ban on AGPs, curtailing the prophylactic use of antibiotics in farmed animals. Further championing this cause, the British Poultry Council implemented a voluntary ban in 2017, covering 90% of broiler production in the UK. This collaborative effort signifies a global commitment to sustainable agriculture practices, heralding a new era in livestock farming that prioritizes health, environmental conservation, and a resilient food ecosystem.
Discover a detailed summary of the report, encompassing market size, forecast, and research methodology. Access the sample report in PDF format @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11087
This trend has increasingly spread across the globe since the EU leading the way back in 2006, followed by South Korea and Indonesia recently, as well as the FDA (US Food and Drug Administration) put to notice and discouraged the (antibiotic growth promotor) use.
Since eubiotics, such as prebiotics, probiotics, enzymes, and organic acids, can add the essential nutritional components to reduce the antibiotic use in farmed animals that can enable the industry to grow further. Key manufacturers like DSM are developing effective eubiotics solutions to reduce the prophylactic use of antibiotics and to remove AGPs to tackle AMR, to switch to antibiotic-free animal diets smoothly over time.
Key Takeaways from the Eubiotics Market Study:
- North American eubiotics market lead in terms of market share and accounts for 31.1% of the global eubiotics market in 2021 exhibiting high demand for the product with the presence of leading manufacturers in the region.
- Organic acid is the dominant type of eubiotics having more antimicrobial and preservative effects as compared to other types of eubiotics. Organic acid accounts for a market share of 48.3% in 2021 of the global market.
- In the form segment, the liquid form is anticipated to witness a lucrative growth rate with a CAGR of 7.8% during the forecast period (2021-2031) for the eubiotics market.
- By function, nutrition and gut health is accounted for 37.9% of the total market share in 2021, while the segment is also expected to witness a lucrative growth rate of 7.5% during the forecast period.
In the livestock segment, aquaculture is anticipated to witness a lucrative growth rate with a CAGR of 8.1% during the forecast period (2021-2031) in the eubiotics market.
“The top manufacturers in the eubiotics market in emerging countries are increasingly inclined towards new innovative technologies for better and efficient product development with sustainable and effective solutions to antibiotics. This factor is owing to the high demand for eubiotics, shooting up the adoption of the product in the global market.” According to a lead analyst at FMI.
Purchase this Premium Research Report | Immediate Delivery Available@ https://www.futuremarketinsights.com/checkout/11087
Who is winning?
According to the Veterinary Medicines Regulation, published on December 11, 2018, the regulatory body has identified the need to control use of antimicrobial farm animal products and has put a ban on the prophylactic and metaphylactic antimicrobials usage in animals. The regulation will come into effect from January 28, 2022, forcing the manufacturers to convert the antibiotic based products into sustainable alternatives like eubiotics.
Some of the leading companies offering eubiotics are Cargill Inc., BASF SE, Koninklijke DSM N.V., Novozymes, Eubiotics, Lesaffre Group, Kemin Industries, Inc., Novus International, Inc., Chr. Hansen Holding A/S, Beneo Group, and others.
Request for our Comprehensive Research Methodology to Understand the Market@ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-11087
By Type, eubiotics is segmented as:
- Probiotics
- Prebiotics
- Organic Acid
- Essential Oil
- Enzymes
By Form, eubiotics is segmented as:
- Dry
- Liquid
By Function, eubiotics is segmented as:
- Nutrition and Gut Health
- Yield
- Immunity
By Livestock, eubiotics is segmented as:
- Cattle
- Poultry
- Swine
- Aquaculture
- Others
By Region, eubiotics is segmented as:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube